| MolName | (Z)-2-cyano-3-[3-(3-morpholin-4-ylsulfonylphenyl)-1-phenylpyrazol-4-yl]-N-(oxolan-2-ylmethyl)prop-2-enamide |
| MolecularFormula | C28H29N5O5S |
| Smiles | N#C/C(/C(NCC1OCCC1)=O)=C/c1cn(-c2ccccc2)nc1-c1cccc(S(N2CCOCC2)(=O)=O)c1 |
| InChI | InChI=1S/C28H29N5O5S/c29-18-22(28(34)30-19-25-9-5-13-38-25)16-23-20-33(24-7-2-1-3-8-24)31-27(23)21-6-4-10-26(17-21)39(35,36)32-11-14-37-15-12-32/h1-4,6-8,10,16-17,20,25H,5,9,11-15,19H2,(H,30,34)/t25-/m1/s1 |
| InChIK | BFTWTXIBDRVMQK-RUZDIDTESA-N |
| TotalMolweight | 547.634 |
| Molweight | 547.634 |
| MonoisotopicMass | 547.18894 |
| CLogP | 1.5412 |
| CLogS | -3.667 |
| H Acceptors | 10 |
| H Donors | 1 |
| TotalSurfaceArea | 410.83 |
| Relative PSA | 0.26296 |
| PolarSurfaceArea | 134.93 |
| Druglikeness | -3.2378 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.46154 |
| Fragments | 1 |
| Non HAtoms | 39 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 1 |
| Rotatable Bond | 7 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 12 |
| Symmetricatoms | 5 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (Z)-2-cyano-3-[3-(3-morpholin-4-ylsulfonylphenyl)-1-phenylpyrazol-4-yl]-N-(oxolan-2-ylmethyl)prop-2-enamide | 2 - (Z)-2-cyano-3-[3-(3-morpholin-4-ylsulfonylphenyl)-1-phenylpyrazol-4-yl]-N-(oxolan-2-ylmethyl)prop-2-enamide